Search Cancer Clinical Trials

The Cancer Center offers patients access to a wide variety of clinical trials of promising new therapies. Use the search tool to find open protocols for your type of cancer.
6 results
  • Head and Neck Cancer, Kidney Cancer, Liver Cancer, Breast Cancer, Colorectal Cancer, Metastatic/Advanced Cancer, Prostate Cancer

19-427          Phase I

A Phase 1 dose escalation study evaluating safety, tolerability and pharmacokinetics of PF-06952229 in adult patients with advanced solid tumors. (View details on

  • Gastric (Stomach) Cancer, Liver Cancer, Esophageal Cancer, Lung Cancer, Metastatic/Advanced Cancer, Brain Tumors, Metastatic

19-812          Phase I

A Phase 1, Open-Label, Multi-Center, First-in-Human Study of the Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity of TPX-0022, a novel MET/CSF1R/SRC inhibitor, in Patients with Advanced Solid Tumors Harboring Genetic Alterations in MET (View details on

  • Liver Cancer, Cellular Therapy

17-033          Phase I

A Phase I Open Label, Clinical Trial Evaluating the Safety and Anti-tumor Activity of Autologous T Cells Expressing Enhanced TCRs Specific for Alpha-fetoprotein (AFPc332T) in HLA-A2 Positive Subjects with Advanced Hepatocellular Carcinoma (HCC) (View details on

  • Lung Cancer, Melanoma, Liver Cancer, Endometrial Cancer

20-196          Phase II

Phase 2 Trial of Voyager V1 (Vesicular Stomatitis Virus Expressing NIS and Human Interferon Beta, VV1), in Combination with Cemiplimab in patients with Hepatocellular Carcinoma, Non-Small Cell Lung Cancer, Melanoma or Endometrioid Endometrial Carcinoma (View details on

  • Liver Cancer

15-287          Phase III

Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of Ramucirumab and Best Supportive Care (BSC) Versus Placebo and BSC as Second-Line Treatment in Patients With Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein (AFP) Following First-Line Therapy With Sorafenib (View details on

Showing 1 - 10 of 6 results